Baku 24° C
BioNTech, Pfizer studying new COVID variant
Health
- 26 November, 2021
- 13:30
BioNTech and Pfizer said that experts are studying a new variant of coronavirus discovered in South Africa, more information is expected in two weeks, Report informs.
“We expect more laboratory data in two weeks at the latest,” BioNTech spokesman said, according to Agence France-Presse.
The company stressed that the data will help to understand whether the variant of coronavirus B.1.1.529 could “require a vaccine adjustment” by Pfizer/BioNTech in the event that it spreads worldwide.
Author
Latest News
20:51
Photo
Mikayil Jabbarov holds cooperation talks with senior official of US State Department
Economy20:38
Cuba's electrical grid collapses in nationwide blackout
Other countries20:15
Warsaw says Russian drone intrusion 'not an accidental event'
Other countries20:02
MALBI-trans aims increasing volume of European cargo on Middle Corridor - EXCLUSIVE
Business19:52
IDF confirms series of Yemen strikes, say they targeted Houthi military camps
Other countries19:26
Pashinyan: Armenia ready to synchronize TRIPP with Azerbaijan's infrastructure
Region19:16
Death toll in Nepal's Gen-Z protests reaches 30, over 1,000 injured
Other countries19:12
Trump to speak with Polish president after Russian drone incursion: W.House
Other countries18:48
Photo